Live Breaking News & Updates on தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் சந்தைப்படுத்தல்

Stay updated with breaking news from தலை ஆஃப் உலகளாவிய பெருநிறுவன தகவல்தொடர்புகள் சந்தைப்படுத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Evotec launches 'beLAB1407' to accelerate translational research from the UK's academic life science


Search jobs
06-May-2021
Evotec launches beLAB1407 to accelerate translational research from the UK s academic life science ecosystem in collaboration with Bristol Myers Squibb
DGAP-News: Evotec SE
/ Key word(s): Miscellaneous
06.05.2021 / 07:30
beLAB1407 TRANSLATES ACADEMIC INNOVATION FROM LEADING ACADEMIC INSTITUTIONS IN THE UK
THE COLLABORATION LEVERAGES EVOTEC S UNIQUE MULTIMODALITY PLATFORM TO VALIDATE FIRST-IN-CLASS THERAPEUTIC CONCEPTS FROM THE UNIVERSITIES OF BIRMINGHAM, EDINBURGH, NOTTINGHAM, AND DUNDEE
BRISTOL MYERS SQUIBB JOINS beLAB1407 AS A BIOPHARMA COLLABORATOR
Hamburg, Germany, 06 May 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company, together with Bristol-Myers Squibb Company (NYSE: BMY), has launched beLAB1407, a new $ 20 m academic BRIDGE to identify and advance novel and breakthrough drug discovery opportuniti ....

United States , United Kingdom , City Of , Great Britain , Andrew Naylor , George Baxter , Werner Lanthaler , David Mcbeth , Thomas Hanke , Volker Braun , Rupert Vessey , David Coleman , Gabriele Hansen , Innovation Development Generation Efficiency , University Of Birmingham Enterprise , Boehringer Ingelheim , University Of Birmingham , Bristol Myers Squibb Company , Distribution Services , University Of Edinburgh , Exonate Ltd , Nottingham Technology Ventures , Head Of Global Corporate Communications Marketing , Bristol Myers Squibb , Biomedical Research , University Of Dundee ,

Evotec AG: Evotec and the GCKD Study Enter into Strategic Collaboration to Build A Unique Molecular Patient Database


Evotec AG: Evotec and the GCKD Study Enter into Strategic Collaboration to Build A Unique Molecular Patient Database
PANOMICS AND EVO
PANHUNTER PLATFORMS
THE GENERATION OF LONGITUDINAL DATA FOR THOUSANDS OF CKD PATIENTS WILL RESULT IN AN UNPRECEDENTED MOLECULAR PATIENT DATABASE
THE STRATEGIC COLLABORATION PROVIDES UNIQUE OPPORTUNITIES TO DEEPEN THE UNDERSTANDING OF DISEASE MECHANISMS, PROGRESSION AND POTENTIAL COMPLICATIONS
HAMBURG and ERLANGEN, GERMANY / ACCESSWIRE / May 4, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and the University Hospital Erlangen today announced a partnership regarding molecular analyses of biospecimens from the German Chronic Kidney Disease ( GCKD ) cohort study. Under the agreement, the research team will make use of Evotec s proprietary ....

Volker Braun , Kai Uwe Eckardt , Mario Schiffer , Gabriele Hansen , Evopanomics Evopanhunter , Steering Committee , University Of Freiburg , University Hospital Erlangen , Boehringer Ingelheim , Evotec Se Frankfurt Stock Exchange , Department Of Nephrology , Head Of The Institute Genetic Epidemiology , Head Of Global Corporate Communications Marketing , Bristol Myers Squibb , Novo Nordisk , Frankfurt Stock Exchange , German Chronic Kidney Disease , Cord Dohrmann , Chief Scientific Officer , Medical Intensive Care , Principal Investigator , Genetic Epidemiology , Action Plan , Global Corporate Communications , Global Investor Relations , வோல்கர் மூளை ,

Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toul


Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse
DGAP-News: Evotec SE
/ Key word(s): Miscellaneous
20.04.2021 / 07:30
J.POD
(R) 2 EU BIOMANUFACTURING WILL PLAY A KEY ROLE IN ADDRESSING THE NEED FOR THERAPEUTIC ANTIBODIES, INCLUDING THOSE RELATED TO INFECTIOUS DISEASES SUCH AS COVID-19
EVOTEC WILL BE SUPPORTED BY THE FRENCH GOVERNMENT AS WELL AS THE OCCITANIE REGION, BPIFRANCE, THE HAUTE-GARONNE PREFECTURE AND TOULOUSE MÉTROPOLE
CONSTRUCTION OF THE J.POD
Hamburg, Germany, 20 April 2021:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that the Company has initiated the construction of its J.POD
(R) 2 EU biologics manufacturing facility at Evotec s Campus Curie in Toulouse, France. J.POD ....

France General , United States , Evotec Toulouse , Toulouse Metropole , Werner Lanthaler , Craig Johnstone , Sanofi Evotec , Volker Braun , Carole Delga , Jean Luc Moudenc , Evotec Biologics , Gabriele Hansen , United States Department Of Defense , Boehringer Ingelheim , Melinda Gates Foundation , Evotec Se Frankfurt Stock Exchange , Distribution Services , Head Of Global Corporate Communications Marketing , Bristol Myers Squibb , Health Campus Of The , Novo Nordisk , Frankfurt Stock Exchange , Campus Curie , United States Department , Occitanie Region , Chief Executive Officer ,